Denmark · Delayed Price · Currency is DKK Pharma Equity Group Statistics
Total Valuation
CPH:PEG has a market cap or net worth of DKK 180.45 million. The enterprise value is 198.20 million.
| Market Cap | 180.45M |
| Enterprise Value | 198.20M |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPH:PEG has 1.23 billion shares outstanding. The number of shares has decreased by -2.29% in one year.
| Current Share Class | 1.23B |
| Shares Outstanding | 1.23B |
| Shares Change (YoY) | -2.29% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.62% |
| Owned by Institutions (%) | 0.14% |
| Float | 888.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.58 |
| P/TBV Ratio | 4.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.02, with a Debt / Equity ratio of 0.47.
| Current Ratio | 8.02 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.36 |
Financial Efficiency
Return on equity (ROE) is -64.39% and return on invested capital (ROIC) is -17.80%.
| Return on Equity (ROE) | -64.39% |
| Return on Assets (ROA) | -16.35% |
| Return on Invested Capital (ROIC) | -17.80% |
| Return on Capital Employed (ROCE) | -33.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.23% in the last 52 weeks. The beta is 0.88, so CPH:PEG's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -44.23% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 63.96 |
| Average Volume (20 Days) | 864,269 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.17M |
| Pretax Income | -22.31M |
| Net Income | -21.02M |
| EBITDA | -18.14M |
| EBIT | -18.17M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 702,000 in cash and 18.45 million in debt, giving a net cash position of -17.75 million or -0.01 per share.
| Cash & Cash Equivalents | 702,000 |
| Total Debt | 18.45M |
| Net Cash | -17.75M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 39.38M |
| Book Value Per Share | 0.03 |
| Working Capital | 53.97M |
Cash Flow
| Operating Cash Flow | -22.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CPH:PEG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.29% |
| Shareholder Yield | n/a |
| Earnings Yield | -11.65% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |